-
CMS rule proposal takes aim at Affordable Care Act plan options
The CMS administrator says the rule would lower costs and reinforce accountability, but critics say it’s designed to steer more consumers toward high-deductible plans.
-
Medicine show: White House launches TrumpRx
The drug platform is designed to reduce the cost of widely used medications, but critics say the prices are still higher than what insurance plans offer.
-
FTC resolves Express Scripts case with ‘landmark settlement’
The pharmacy benefits manager has copped to artificially inflating the list price of drugs by using unfair rebating practices.
-
Former Seahawks tight end convicted in $200m healthcare fraud scheme
Joel Rufus French pressured elderly Americans to provide their personal and health insurance information and accept unnecessary orthotic braces.
-
FDA launches program to bolster domestic drug manufacturing
The PreCheck program aims to make it significantly less onerous to set up domestic manufacturing plants provided they align with US national priorities.
-
CMS proposes financial incentives for hospitals to buy American supplies
The proposed rule change appears to be an acknowledgement that shifting supply chains to domestic manufacturers would significantly strain hospital operating margins.
-
‘I wouldn’t dare take these drugs’: how China supplies untested peptides to the west
The success of weight-loss drugs has driven demand for injectable compounds that claim to improve everything from sleep to skin.
-
UK to regulate AI in healthcare as majority supports use
The move comes amid a surge in patients self-diagnosing using online tools like chatbots.